Alan B. Lancz & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $312K | Hold |
6,750
| – | – | 0.31% | 86 |
|
|
2025
Q1 | $412K | Hold |
6,750
| – | – | 0.44% | 62 |
|
|
2024
Q4 | $382K | Sell |
6,750
-600
| -8% | -$33.9K | 0.39% | 69 |
|
|
2024
Q3 | $380K | Hold |
7,350
| – | – | 0.35% | 78 |
|
|
2024
Q2 | $305K | Buy |
+7,350
| New | +$305K | 0.3% | 92 |
|
|
2023
Q4 | $372K | Sell |
7,250
-3,100
| -30% | -$159K | 0.39% | 75 |
|
|
2023
Q3 | $601K | Buy |
10,350
+100
| +1% | +$5.8K | 0.68% | 36 |
|
|
2023
Q2 | $655K | Hold |
10,250
| – | – | 0.7% | 33 |
|
|
2023
Q1 | $710K | Sell |
10,250
-100
| -1% | -$6.93K | 0.74% | 30 |
|
|
2022
Q4 | $750K | Hold |
10,350
| – | – | 0.76% | 31 |
|
|
2022
Q3 | $736K | Hold |
10,350
| – | – | 0.87% | 26 |
|
|
2022
Q2 | $764K | Sell |
10,350
-300
| -3% | -$22.1K | 0.76% | 29 |
|
|
2022
Q1 | $778K | Buy |
10,650
+700
| +7% | +$51.1K | 0.69% | 33 |
|
|
2021
Q4 | $620K | Buy |
+9,950
| New | +$620K | 0.54% | 50 |
|